), Borman B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978 -1992 . International Journal of Ep/'ctem/o/op;y 1996; 25: 941-947. Background. Increasing incidence rates for adenocarcinomas of the oesophagus and gastric cardia have been reported from the United States, Denmark, United Kingdom, Switzerland, and Sweden. This paper reports on the incidence of adenocarcinomas of the oesophagus and gastric cardia in New Zealand in the Maori (Polynesian), and non-Maori (predominantly European) populations. Methods. Incidence data from the National Cancer Registry for 1978 through 1992 were used to compute age-adjusted rates by sex, ethnic group, anatomic subsite, morphology, 14 area health districts, and for three periods: 1978-1982, 1983-1987 and 1988-1992. Statistical tests for significance of trends and differences in frequencies were employed. Results. Incidence rates for adenocarcinoma of the oesophagus are increasing in non-Maori men and women, but at a lesser rate than that reported for the US. The rate of 2.3 per 100 000 population (1988)(1989)(1990)(1991)(1992) for non-Maori men is similar to the rate for US white men of 2. 5 (1988-1990). Rates for adenocarcinoma of the gastric cardia in non-Maori men declined from 2.5 in 1983-1987 to 1.9 in 1988-1992, and were stable at 0.4 in non-Maori women. However, rates for cases with unspecified anatomic subsite fluctuated over the 15-year period and probably caused a deflation in rates in the most recent 5-year period. Conclusions. The incidence patterns of adenocarcinomas of the oesophagus and gastric cardia in New Zealand should be monitored over the next decade for confirmation of the trends observed here. There is need to review the quality of the data in the New Zealand registry.
Increasing incidence rates for adenocarcinomas of the oesophagus and gastric cardia have been reported from the United States, 1 " 3 Denmark, United Kingdom, 4 Switzerland, 5 and Sweden. 6 In the US, the average annual age-adjusted incidence rates of adenocarcinoma of the oesophagus among white men tripled from 0.8 per 100 000 in 1976 through 1978 to 2.5 per 100 000 in [1988] [1989] [1990] . 3 ' 7 The rates for adenocarcinoma of the gastric cardia increased from 2.3 to 3.4 per 100 000. In France, no changes in rates are apparent. 8 This paper reports on a study to determine if the incidence rates of adenocarcinomas of the oesophagus and gastric cardia are changing in New Zealand by sex and ethnic group using cancer registration data.
Little is known about the aetiology of these adenocarcinomas and the reasons for their changing incidence rates. Associations of increased risk have been reported with Barrett's syndrome of the oesophagus, 9 use of alcohol and tobacco, 10 " high consumption of beef and smoked foods, 10 low income, and history of ulcer" and obesity. 12 Decreased risk was observed in one study with diets rich in raw fruit and vegetables, and fibre. 12 In histological terms, oesophageal cancers are predominantly squamous cell carcinomas of various degrees of differentiation. Stomach cancers on the other hand are predominantly adenocarcinomas. Primary adenocarcinomas of the oesophagus are comparatively rare and occur mostly in the lower third of the oesophagus. They originate from dystopic islands of the gastric mucosa, persistent embryonal islands of the columnar epithelium or from mucous glands of the oesophageal wall, or they occur in the course of Barrett's syndrome, a glandular mucosal metaplasia with inflammatory stenosis acquired through chronic reflux oesophagitis. 13 Adenocarcinoma of the cardia much more closely resembles adenocarcinoma confined to the oesophagus and adenocarcinoma associated with Barrett's syndrome, than it does adenocarcinoma elsewhere in the stomach.
14 Adenocarcinoma of the cardia or lower oesophagus cannot be considered as typical stomach cancer that has spread to the oesophagus; it is a distinct subgroup.
14 However, it remains uncertain just how closely this subgroup resembles the adenocarcinoma confined to the oesophagus. 13 
New Zealand
New Zealand had a population of 3.4 million in 1991, with 74% European, 13% Maori, 4% Pacific Island Polynesian, and 9% other ethnic groups. Mortality and morbidity statistics are reported for two groups: 'Maori' and 'non-Maori'. Morbidity and mortality rates of cancer of the oesophagus have been stable or slowly rising since 1973, while rates for cancers of the stomach have been declining steadily since 1951. 15 In 1988-1991, age-adjusted death rates per 100 000 for cancers of the oesophagus among Maori were 5.1 for men and 1.7 for women; for non-Maori 5.5 and 2.1, respectively. For cancers of the stomach, death rates in Maori men were 18.9 and in women 10.0; and in non-Maori men 8.4 and in women 4.0. 16 Incidence rates for cancers of the oesophagus and stomach by anatomic subsite and by morphology have not been compiled for the New Zealand population. An epidemiologic-pathologic study of a series of stomach cancer cases from 1950-1970 was made by Kubo, 17 but more recent data from the New Zealand cancer registry has not been examined.
METHODS
People diagnosed as having cancer of the oesophagus and stomach from 1978-1992 were identified through the National Cancer Registry of the New Zealand Health Information Service, Ministry of Health. This population-based registry dates from 1948 and has maintained approximately 95% complete registration of tumours from all known sources of cancer diagnoses in public and private hospitals, death certificates, and autopsy reports. 18 Completeness of registration as verified by comparison with death certificates is approximately 85% for both oesophageal and stomach cancers in the New Zealand registry. 18 The information recorded in the registry is drawn from registry forms, most of which are completed by medical records clerks transcribing information from clinical and pathological reports in case files in the diagnostic centres. The cancer cases were classified according to age (5-year age groups to 85+ years), sex, and ethnic group (Maori and non-Maori). This information is obtained by the Registry from case files in the diagnostic centres. Using a FORTRAN computer program we calculated incidence rates age-adjusted by the direct method to Segi's world population. 18 Rates were calculated for three time periods : 1978-1982, 1983-1987 and 1988-1992 . The statistical significance of time trends in the age-adjusted rates were tested using Snedecor's test for linear trend in proportions. 20 The numbers and proportions of cases with unspecified morphology, and by stage of tumour at diagnosis, were compiled for each of the 14 area health boards in effect in New Zealand in 1992, and statistical significance of differences from observed and expected frequencies tested with y}. Estimates of the average usually resident New Zealand population by sex and ethnic group for 1980, 1985 and 1990 were used for the population denominators in rate calculation in the respective three time periods. Population data were supplied by Statistics New Zealand for December-ending years. These methods closely follow those of Blot et al?
RESULTS

Oesophageal Cancer
During the period from 1978 to 1992, 2450 oesophageal cancers were registered in New Zealand ( Table 1 ). The a Rates per 100 000 population adjusted by the direct method using Segi's world population a average annual age-adjusted incidence rates for all cancers of the oesophagus increased slowly from 1978-1982 to 1988-1992 in Maori men and women and nonMaori men but were stable in non-Maori women. None of these trends were statistically significant at the 5% level. The age-dependent male to female rate ratio is about 2:1 in both ethnic groups. The pattern of distribution by anatomic site is similar between the sexes and ethnic groups except for a much larger proportion (48%) of tumours in the lower third in non-Maori men. Squamous cell carcinomas predominate in Maori men (66%), Maori women (75%), and non-Maori women (56%), but in non-Maori men adenocarcinomas comprise 38% and squamous cell 37% (Table 2 ). For sitespecified cases, about two-thirds of the squamous cell carcinomas were evenly distributed in the lower twothirds of the oesophagus, while over 80% of the adenocarcinomas were in the lower one-third in all sex and ethnic groups. Incidence rates for squamous cell carcinomas are highest in Maori men at 5.3 per 100 000 (Table 3) . Rates for squamous cell carcinomas in Maori men and women and for non-Maori women were considerably higher than their rates for adenocarcinomas; for non-Maori men the rates were similar.
Incidence rates in Figure 1 indicate an increase in adenocarcinomas of the oesophagus in non-Maori men from 1.8 to 2.3 per 100 000 population, and in women from 0.3 to 0.5 between 1978-1982 and 1988-1992. There were only eight cases among Maori men and no cases among Maori women during the 15-year period. Rates for squamous cell carcinomas in all populations were stable or declined slightly. By 1988-1992, adenocarcinomas made up 40% of all oesophageal cancers among non-Maori men, while for Maori men and women, and non-Maori women, the proportions were: 12%, 0%, and 18%, respectively. The rising incidence affected all age groups. None of the trends shown in Figure 1 were statistically significant at the 5% level.
From 1978-1992, 31% of all oesophageal cancers were unspecified for anatomic subsite and 12% were unspecified for morphology (Table 2 ). These proportions also fluctuated over the three 5-year periods: the proportions of unspecified subsite in 1978-1982, 1983-1987, and 1988-1992 , were 47%, 17%, and 32%, respectively, and for unspecified morphology were 13%, 8% and 15% respectively. Examination of the proportion of cases with unspecified morphology and by stage of tumour at diagnosis, in the 14 area health board districts, found no statistically significant differences between districts.
Stomach Cancer
During the period 1978-1992, there were 6011 stomach cancers registered in New Zealand ( Table 1 ). The average annual age-adjusted incidence rates for all cancers of the stomach decreased steadily in all sex and ethnic groups from 1978-1982 to 1988-1992 , although none of these trends were statistically significant at the 5% level. The age-dependent male to female rate ratio is about 2:1 in both ethnic groups. There were no cases of squamous cell carcinoma of the stomach in Maori of either sex in this period (Table 2) . Among non-Maori of both sexes they accounted for only 1% of all cases, (13) 138 (15) 929 (100) 234 (10) 1038 (45) 1006 (45) 18 (1) 1409 (62) 387 (17) 464 (20) 2278 (100) and over two-thirds were in the gastric cardia. Adenocarcinomas were the predominant morphological type but distribution in the cardia varied: 25% for non-Maori men, while the proportions for Maori men and women and non-Maori women were 5%, 4%, and 12%, respectively. The incidence rate of 2.2 per 100 000 for adenocarcinoma of the cardia among non-Maori men is over twice the rate in Maori men, and over three times the rate among women (Table 3) . Conversely, the rate of adenocarcinomas elsewhere in the stomach among Maori men was over twice that of non-Maori men, and the rate among Maori women over three times that of non-Maori women.
Incidence rates shown in Figure 1 indicate stable to slightly declining rates for adenocarcinoma of the gastric cardia in non-Maori men from 2.2 to 1.9 per 100 000 population, and in women from 0.5 to 0. 4 between 1978-1982 and 1988-1992 . There were only nine cases of adenocarcinoma of the gastric cardia in Maori men, and only six cases in Maori women during the 15-year period, too few to compute reliable rates. Rates for adenocarcinomas elsewhere in the stomach have declined among non-Maori men while in all other groups there was a rise from 1978-1982 to 1983-1987, followed by a decline. By 1988-1992, adenocarcinomas of the cardia made up 27% of all stomach cancers in non-Maori men, while for Maori men and women, and non-Maori women, the proportions were 7%, 4%, and 12%, respectively. Among non-Maori men, agespecific incidence rates for adenocarcinomas of the cardia were stable until age 75 years; thereafter there was considerable variation between the three time periods because of the small number of cases. The combined incidence rates for adenocarcinomas of the oesophagus and gastric cardia in 1988-1992 for Maori men and women were 2.4 and 0.5 per 100 000 population, respectively; and for non-Maori men and women 4.2 and 0.8, respectively. None of the trends shown in Figure 1 were statistically significant at the 5% level.
From 1978-1992, 41% of stomach cancers were unspecified for anatomic subsite and 16% were unspecified for morphology (Table 2 ). These proportions also fluctuated over the three 5-year periods: the proportions of unspecified subsite in 1978-1982, , 1978-1982, 1983-1987 and 1988-1992 1983-1987, and 1988-1992, were 45%, 33%, and 46%, respectively; and for unspecified morphology were 18%, 13% and 18%, respectively. Examination of the proportion of cases with unspecified morphology, and by stage of tumour at diagnosis, in the 14 area health board districts, found no statistically significant differences between districts.
DISCUSSION
While none of the trends are statistically significant, the results indicate that rates for adenocarcinoma of the oesophagus are slowly increasing in nonMaori (predominantly European) men and women in New Zealand but at a lesser rate of increase than that reported for the US. 3t7 The rate for adenocarcinoma of the oesophagus in New Zealand among non-Maori men of 2.3 per 100 000 (1988) (1989) (1990) (1991) (1992) ) is similar to the rate in the US for white men of 2.5 per 100 000 (1988) (1989) (1990) . 3 -7 Rates for adenocarcinoma of the gastric cardia in non-Maori men declined in the most recent 5-year period and remained stable in women. Thus, in this time period, the non-Maori population did not experience the rate of increase in adenocarcinoma of the gastric cardia observed in the US and other countries. However, in the US, there was no further increase in rate of adenocarcinoma of the cardia in white males from [1988] [1989] [1990] . 7 Among all cancers with known stomach location, the proportions of adenocarcinomas of the cardia in Maori men and women, and New Zealand, 1978 -1992 non-Maori men and women (based on numbers in Table 2 ), were 8%, 6%, 35%, and 20%, respectively. This compares to findings in the US where the proportions in 1984-1987 for black men and women and white men and women were 18%, 13%, 47% and 19%, respectively. 3 In New Zealand, the case numbers among Maori are too small to determine if the comparatively low proportion of cases in the cardia for the entire 1978-1992 period has changed in recent years.
However, the apparent increase in rates of adenocarcinoma of the cardia in Maori men is of concern and deserves special monitoring in the next decade.
The degree to which the New Zealand registry data could be affected by methodological practices was reviewed. The percentages of unspecified anatomic subsite shown in Table 2 , 31% for all oesophageal and 41% for all stomach cancers, are comparable to rates reported from other registries. Blot et al. reported a rate of 29% incomplete subsite registration for cancers of the stomach in the nine SEER registries in the US. 3 In New Zealand, the lower rates of unspecified anatomic subsites and morphologies reported for 1983-1987, which produce the rate fluctuation over the three time periods, are most likely due to a special effort made by registry staff during this time to improve registry quality, especially through consultations with medical records clerks, clinicians and pathologists to amplify reports. This effort was not sustained in recent years possibly because of restructuring of the ministry housing the registry, budget constraints, and staff changes.
The degree to which the increase in proportion of unspecified subsites in 1988-1992 may have affected rates for adenocarcinomas of the oesophagus and gastric cardia is difficult to assess. There is no obvious consistent relationship between the unspecified and specified anatomic subsite rates. If there has been an effect it would most likely have depressed the rates in the most recent 5-year period, especially in the gastric cardia. Thus it is possible that rates for non-Maori in recent years have increased rather than declined, and that the rates for Maori men have increased more than was observed here.
There is no evidence of changes in diagnostic techniques or practice in reporting at diagnostic centres around the nation that might contribute to changes in rates. This is supported by the absence of statistically significant differences in the proportions of stage of tumour at diagnosis by the 14 area health board districts. In summary, we believe that the incidence rates reported here for 1988-1992 have probably been affected by an increased proportion of cases in which the subsite was not specified. No other known possible artefacts appear important. The relative differences in rates by sex and ethnic group, and by subsite and morphology, are probably accurate.
The observed trends in incidence of these cancers in New Zealand may be associated with the same risk factors reported in other countries. Alcohol consumption in the adult population (aged 15 and over) has been slowly falling since 1977, when the consumption per person per year reached 12 litres. 21 Seventy per cent is consumed by men, and while Maori men consume about as much on average as non-Maori men, they are inclined to binge drinking and the average amount consumed during a drinking session is nearly twice as much as by non-Maori. 22 While 27% of the adult population smoke cigarettes, 50% of Maori smoke.
23 New Zealand's per capita consumption rates of beef and other red meats are among the highest in the world. 16 The incidence patterns of adenocarcinomas of the oesophagus and gastric cardia in New Zealand should be monitored over the next decade for confirmation of the trends observed here. However, even if the trends are found to be of concern, the small numbers of cases in New Zealand precludes epidemiological studies of causal associations. Results of epidemiological studies now ongoing in larger populations may give clues as to the cause and preventive measures for these cancers that might then be applicable to the New Zealand population. Lastly, there is need to review the quality of the data in the New Zealand cancer registry, which should include evaluation of all stages of recording, reporting and coding.
